Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sembiosys Genetics Inc.
SBIYF
Healthcare
Biotechnology
"SemBioSys Genetics Inc is engaged in developing high-value proteins and oils in plant seeds using its unique proprietary genetic expression and manufacturing technology platforms. The Company has operations in United States and Canada."
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:SBIYF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(0)
•••
RE38
X
View Profile
View Bullboard History
Post by
RE38
on Feb 19, 2012 11:23am
A little teaser
Here's a little teaser to what our resident banned big mouth jharbaugh has promised. The first 3 paragraphs of a 9 paragraph article that will be getting published by the individual who wrote this
...more
(16)
•••
Horn1369
X
View Profile
View Bullboard History
Post by
Horn1369
on Feb 19, 2012 2:18am
Interesting PDF
https://www.sembiosys.com/pdf/Annual_report_06.pdf
G Mining Ventures Reports Third Quarter 2024 Production and Financial Results
posted Nov 15, 2024 9:00am by
G Mining Ventures Corp.
-
|
"I am proud to reflect on the significant milestones achieved this quarter, from our first gold pour and the launch of commercial production at TZ, to the release of robust PEA results for the generational Oko West project, to the acquisition of the highly prospective CentroGold project in Brazil," commented Louis-Pierre Gignac, President & Chief Executive Officer, "These results ...read more
(16)
•••
Horn1369
X
View Profile
View Bullboard History
Post by
Horn1369
on Feb 19, 2012 1:47am
Industry Canada on Sembiosys
Project Highlight"Technology Partnerships Canada was a critical element in the development of SemBioSys. It allowed us to transform our technology from scientific principle to a commercially
...more
(0)
•••
RE38
X
View Profile
View Bullboard History
Post by
RE38
on Feb 18, 2012 6:30pm
30% of revenues not enough?
Some people say 30% of revenues is a bad deal for SBS? But Tasly is taking on 100% of the costs. That's an awesome deal for SBS imo. Many companies would kill for 30% margin (100%-70% costs) and
...more
(0)
•••
CurlyMick
X
View Profile
View Bullboard History
Comment by
CurlyMick
on Feb 18, 2012 4:16pm
RE: SBS-1000 and Apo AI Milano
Agreed. I play day, swing and long-term stories. I like both value and growth. I'm already on this one, but just missing that one key piece of info to decide what level I want to play
...more
(16)
•••
Horn1369
X
View Profile
View Bullboard History
Post by
Horn1369
on Feb 18, 2012 12:39pm
SBS-1000 and Apo AI Milano
Are company makers but they will not be seating on their hands waiting for approvals instead they will be busy commercializing their health products with Tasly and collecting 30% of the sales in one
...more
(0)
•••
CurlyMick
X
View Profile
View Bullboard History
Comment by
CurlyMick
on Feb 18, 2012 11:39am
RE: RE: RE: RE: RE: Pay attention to the news
Oh, sorry for my ignorance. I thought that their results at phase I and II were already posted. That must have been pre-pre-clinical trials? Aha...I just went back and read it more closely...it
...more
(16)
•••
Horn1369
X
View Profile
View Bullboard History
Comment by
Horn1369
on Feb 18, 2012 11:19am
RE: RE: RE: RE: Pay attention to the news
They are still in pre clinical according to the email reply I got from Rick Pierce. "Hi, I would like to know if you have applied for FDA approval for Apo AI milano and the SBS-1000 (insulin) and
...more
(16)
•••
Horn1369
X
View Profile
View Bullboard History
Comment by
Horn1369
on Feb 18, 2012 11:13am
RE: RE: RE: Pay attention to the news
The important news here is that they are going to monetize their patents and health products and their technology much much sooner than if they were on their own. there is also the possibility of
...more
(0)
•••
CurlyMick
X
View Profile
View Bullboard History
Comment by
CurlyMick
on Feb 18, 2012 10:56am
RE: RE: RE: Pay attention to the news
Thanks Viking. I read their PR this way. Tasly has the right to do what they want and will guide the company in any way they can as they work together; yet, SBS is not restricted to working
...more
(0)
•••
VIKINGSTORM
X
View Profile
View Bullboard History
Comment by
VIKINGSTORM
on Feb 18, 2012 8:01am
RE: RE: Pay attention to the news
I phoned the Calgary office yesterday with limited success because during the day I work in a very marginal cell phone area. However, I did get that first and foremost will be the introduction of
...more
(0)
•••
CurlyMick
X
View Profile
View Bullboard History
Comment by
CurlyMick
on Feb 18, 2012 2:58am
RE: Pay attention to the news
Insulin is first and foremost for medical apps correct? The company's site does not talk about a phase III testing and approval procedure that I can see except what's at the bottom of my post.
...more
(16)
•••
Horn1369
X
View Profile
View Bullboard History
Post by
Horn1369
on Feb 18, 2012 2:39am
Pay attention to the news
SemBioSys and Tasly Pharmaceutical Joint Venture Receives Chinese Government Approvals and Business License New Joint Venture Focused on Multi-Million Dollar Short-Term Revenue
...more
(0)
•••
skibber87
X
View Profile
View Bullboard History
Comment by
skibber87
on Feb 18, 2012 12:22am
RE: RE: RE: RE: RE: RE: RE: RE: Hard 1 to figure .
don't mind vikingstorm, somthing is lacking in his life so he sees fit to take it out on people in forums, its quite sad really......
(0)
•••
joeybaby
X
View Profile
View Bullboard History
Comment by
joeybaby
on Feb 18, 2012 12:00am
RE: RE: RE: RE: RE: RE: RE: Hard 1 to figure ....
All I ever said was dont buy SBS. Its a tough market if you got no winners
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Major Funding Secured! Company Closes First Round of Private Placement
This $10M Deal Could Reshape the Future of Global Creator Platforms
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Gold, growth and sustainability in focus for this resource company
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
New Gold and Copper Hotspot Identified – What’s Next for This Serbian Project?
Explained: The Psychology of Options Trading with Practical Tips
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023